{"id":213,"date":"2023-09-28T11:32:00","date_gmt":"2023-09-28T16:32:00","guid":{"rendered":"https:\/\/www.rqmplus.com\/?post_type=scb-resources&#038;p=213"},"modified":"2025-06-05T15:51:32","modified_gmt":"2025-06-05T20:51:32","slug":"eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance","status":"publish","type":"scb-resources","link":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/","title":{"rendered":"EU MDR Timelines and Fine Lines: Unraveling Critical Transition Nuances to Gain Compliance"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" width=\"960\" height=\"540\" src=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/live_72_on_demand_promo.webp\" alt=\"recorded 28 september 2023 eu mdr timelines and fine lines unraveling transition nuances and achieving compliance live #72\" class=\"wp-image-256\" style=\"width:550px\" srcset=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/live_72_on_demand_promo.webp 960w, https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/live_72_on_demand_promo-300x169.webp 300w, https:\/\/www.rqmplus.com\/wp-content\/uploads\/2024\/05\/live_72_on_demand_promo-768x432.webp 768w\" sizes=\"(max-width: 960px) 100vw, 960px\" \/><\/figure>\n\n\n\n<p>The extension of the EU MDR compliance timeline offers a reprieve for medical device manufacturers, but this extended window comes with its own set of challenges and conditions.&nbsp;<strong>As the interim deadlines approach, it\u2019s critical for manufacturers to fully understand their obligations and the ramifications of failing to meet them.<\/strong><\/p>\n\n\n\n<p>In this high-impact panel discussion, thought leaders from a notified body,&nbsp; manufacturer, and RQM+ come together to unpack the complex landscape of EU MDR compliance in light of Regulation 2023\/607 and the transition from MDD\/AIMDD to MDR 2017\/745.<\/p>\n\n\n\n<p>This is a must-attend session for those dealing with legacy device transitions and meeting upcoming MDR deadlines.<\/p>\n\n\n\n<p>Topics will include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Understanding key dates<\/strong>: The anatomy of interim deadlines and the conditions for extended transitional arrangements<\/li>\n\n\n\n<li><strong>Mastering documentation<\/strong>: What manufacturers need to include in their MDR applications for a successful assessment by notified bodies<\/li>\n\n\n\n<li><strong>Staying compliant<\/strong>: Best practices for incorporating the requirements of MDR 2017\/745 into existing Quality Management Systems<\/li>\n\n\n\n<li><strong>Certificates and self-declarations<\/strong>: Proving the extended validity of your device\u2019s CE certificate and navigating self-declaration protocols<\/li>\n\n\n\n<li><strong>Risk management<\/strong>: Avoiding common pitfalls that can delay or derail your transition to MDR compliance<\/li>\n\n\n\n<li><strong>A look into the future<\/strong>: How early compliance can give manufacturers a competitive edge and allow for design and market adaptability<\/li>\n<\/ul>\n\n\n\n<p>Attendees will leave the session equipped with actionable insights for navigating this complex regulatory environment, including a deeper understanding of the strategic and tactical steps needed for a successful transition.<\/p>\n\n\n\n<p>Panelists:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sharmila Gardner \u2013 Technical Documentation Manager &amp; Head of UK Approved Body, Intertek<\/li>\n\n\n\n<li>Brian Dahl \u2013 Vice President of Quality and Regulatory, Starkey<\/li>\n\n\n\n<li>Jaishankar (Jai) Kutty, Ph.D. \u2013 Vice President, Intelligence &amp; Innovation, RQM+<\/li>\n\n\n\n<li>Matt Burger \u2013 Vice President, Business Development, RQM+ (moderator)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>The extension of the EU MDR compliance timeline offers a reprieve for medical device manufacturers, but this extended window comes&#8230;<\/p>\n","protected":false},"author":2,"featured_media":157,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"resource-type":[6],"topic":[9],"class_list":["post-213","scb-resources","type-scb-resources","status-publish","has-post-thumbnail","hentry","resource-type-rqm-live","topic-regulatory-quality"],"acf":[],"card_info":{"title":"EU MDR Timelines and Fine Lines: Unraveling Critical Transition Nuances to Gain Compliance","link":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/","link_target":"_self","name":"RQM+ Live!","slug":"rqm-live","thumbnail":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg","excerpt":"The extension of the EU MDR compliance timeline offers a reprieve for medical device manufacturers, but this extended window comes...","display_date":"September 28, 2023"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EU MDR Transition: Key Deadlines and Compliance Strategies | RQM+<\/title>\n<meta name=\"description\" content=\"Watch our on-demand panel discussion to understand the extended EU MDR compliance timelines, critical interim deadlines, and best practices for successful transition and compliance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU MDR Transition: Key Deadlines and Compliance Strategies | RQM+\" \/>\n<meta property=\"og:description\" content=\"Watch our on-demand panel discussion to understand the extended EU MDR compliance timelines, critical interim deadlines, and best practices for successful transition and compliance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/\" \/>\n<meta property=\"og:site_name\" content=\"RQM+\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RQMplus\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-05T20:51:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1800\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@RQMplus\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/\",\"url\":\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/\",\"name\":\"EU MDR Transition: Key Deadlines and Compliance Strategies | RQM+\",\"isPartOf\":{\"@id\":\"https:\/\/www.rqmplus.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg\",\"datePublished\":\"2023-09-28T16:32:00+00:00\",\"dateModified\":\"2025-06-05T20:51:32+00:00\",\"description\":\"Watch our on-demand panel discussion to understand the extended EU MDR compliance timelines, critical interim deadlines, and best practices for successful transition and compliance.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/#primaryimage\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg\",\"width\":1800,\"height\":1200,\"caption\":\"Pulse monitor on someone's finger.\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rqmplus.com\/#website\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"name\":\"RQM+\",\"description\":\"Evolving MedTech\",\"publisher\":{\"@id\":\"https:\/\/www.rqmplus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rqmplus.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rqmplus.com\/#organization\",\"name\":\"RQM+\",\"url\":\"https:\/\/www.rqmplus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"contentUrl\":\"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png\",\"width\":696,\"height\":696,\"caption\":\"RQM+\"},\"image\":{\"@id\":\"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/RQMplus\",\"https:\/\/x.com\/RQMplus\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU MDR Transition: Key Deadlines and Compliance Strategies | RQM+","description":"Watch our on-demand panel discussion to understand the extended EU MDR compliance timelines, critical interim deadlines, and best practices for successful transition and compliance.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/","og_locale":"en_US","og_type":"article","og_title":"EU MDR Transition: Key Deadlines and Compliance Strategies | RQM+","og_description":"Watch our on-demand panel discussion to understand the extended EU MDR compliance timelines, critical interim deadlines, and best practices for successful transition and compliance.","og_url":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/","og_site_name":"RQM+","article_publisher":"https:\/\/www.facebook.com\/RQMplus","article_modified_time":"2025-06-05T20:51:32+00:00","og_image":[{"width":1800,"height":1200,"url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@RQMplus","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/","url":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/","name":"EU MDR Transition: Key Deadlines and Compliance Strategies | RQM+","isPartOf":{"@id":"https:\/\/www.rqmplus.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/#primaryimage"},"image":{"@id":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg","datePublished":"2023-09-28T16:32:00+00:00","dateModified":"2025-06-05T20:51:32+00:00","description":"Watch our on-demand panel discussion to understand the extended EU MDR compliance timelines, critical interim deadlines, and best practices for successful transition and compliance.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/resources\/eu-mdr-timelines-and-fine-lines-unraveling-critical-transition-nuances-to-gain-compliance\/#primaryimage","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/01\/AdobeStock_334138696.jpg","width":1800,"height":1200,"caption":"Pulse monitor on someone's finger."},{"@type":"WebSite","@id":"https:\/\/www.rqmplus.com\/#website","url":"https:\/\/www.rqmplus.com\/","name":"RQM+","description":"Evolving MedTech","publisher":{"@id":"https:\/\/www.rqmplus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rqmplus.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rqmplus.com\/#organization","name":"RQM+","url":"https:\/\/www.rqmplus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","contentUrl":"https:\/\/www.rqmplus.com\/wp-content\/uploads\/2025\/02\/logo.png","width":696,"height":696,"caption":"RQM+"},"image":{"@id":"https:\/\/www.rqmplus.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RQMplus","https:\/\/x.com\/RQMplus"]}]}},"_links":{"self":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/scb-resources\/213","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/scb-resources"}],"about":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/types\/scb-resources"}],"author":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":0,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/scb-resources\/213\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media\/157"}],"wp:attachment":[{"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/media?parent=213"}],"wp:term":[{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/resource-type?post=213"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/www.rqmplus.com\/wp-json\/wp\/v2\/topic?post=213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}